Xenobiotica · 1997 · 26 citations · 18 references
Life SciencesBiochemistryMicrobiologyDrug MetabolismMetabolismMicrobial MetabolismFungal MetabolismFungal Secondary MetabolitesMetabolite IdentificationMicrobial Metabolite ProductionMicrobial Natural Product BiosynthesisSecondary Metabolite ProductionBioactive Fungal MetabolitesBiotransformationFungal Bioactive CompoundsIsolationMicrobial Secondary MetabolitesPhase Ii Metabolite IdentificationSecondary Metabolite DiscoverySecondary Metabolites
1. Biotransformation of warfarin by the fungus Beauveria bassiana (ATCC 7159) yielded the first reported phase II warfarin metabolite, 3'4'-dihydroxywarfarin-3'-[4-methoxyglucoside], another previously unreported metabolite, 3',4'-dihydroxywarfarin and also 4'-hydroxywarfarin. 2. Biotransformation of warfarin by Streptomyces rimosus (NRRL 2234) yielded the previously unreported metabolites, 12-hydroxywarfarin, 4'-hydroxy-11-methoxywarfarin, and also 7-hydroxywarfarin and 4'-hydroxywarfarin, which have not been previously reported as biotransformation products from this organism. 3. Hplc-nmr has been used to identify biotransformation products of warfarin by S. rimosus directly from the microbial broth without prior isolation and purification.
18
Elsevier Sdol · 2009 · 573 citations
Structure of warfarin in solution
E. Valente, E. C. Lingafelter, William R. Porter et al. · Journal of Medicinal Chemistry · 1977 · 91 citations